Thema: US56400P7069
MNKD, US56400P7069
trading-7626924_1920.jpg - Foto: THN
MannKind stock sets November 5 date for third-quarter results
MannKind stock will report third-quarter results after the US market closes on November 5. Management will discuss the figures in a webcast.
ad-hoc-news.de, heute 00:27 Uhr
MNKD, US56400P7069
Chardan starts coverage of MannKind stock with a USD 10.00 ...
Second-quarter revenue reached USD 109.37 million versus USD 108.92 million consensus. MannKind stock costs EUR 2.78 on October 20, 2026 at 8:13 p.m. CEST.
ad-hoc-news.de, 20.10.26 20:21 Uhr
MNKD, US56400P7069
MannKind stock falls 4.70 percent to USD 3.04 on Nasdaq ...
MannKind stock fell 4.70 percent to USD 3.04 on Nasdaq on October 16, 2026. Second-quarter revenue rose 43.00 percent year over year.
ad-hoc-news.de, 17.10.26 21:39 Uhr
MNKD, US56400P7069
MannKind stock rises 4.54 percent on Nasdaq at EUR 2.81
Truist set USD 5.00 on October 7, 2026. MannKind stock costs EUR 2.81 on October 15, 2026, up 4.54 percent on Nasdaq.
ad-hoc-news.de, 15.10.26 21:00 Uhr
MNKD, US56400P7069
MannKind stock fell 3.8 percent as analysts kept a positive ...
MannKind stock closed at USD 3.80 on October 2 after a 3.80 percent decline. Second-quarter revenue rose 43 percent, while analysts kept a Moderate Buy view.
ad-hoc-news.de, 04.10.26 16:12 Uhr
FDA, Approves
FDA Approves Key Prescribing Update for MannKind’s Inhaled ...
MannKind US56400P7069
boerse-global.de, 27.01.26 10:12 Uhr
MannKind, Secures
MannKind Secures Key FDA Milestones Amid Pipeline Reprioritization ...
MannKind US56400P7069
boerse-global.de, 10.12.25 11:37 Uhr
MannKind, Stock
MannKind Stock: Navigating Clinical Setbacks and Financial ...
